Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2
Authors:
Open Access
- 29 January 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (2) , 1899-1909
Abstract
The functions and molecular regulatory mechanisms of miR-193a-3p in cardiac injury induced by obstructive sleep apnea (OSA) are poorly understood. This study aimed to explore the role of miR-193a-3p in intermittent hypoxia(IH)-induced human umbilical vein endothelial cells (HUVECs) injury. In this study, we found that IH significantly decreased viability but enhanced cell apoptosis. Concurrently, the miR-193a-3p expression level was increased in HUVECs after IH. Subsequent experiments showed that IH-induced injury was ameliorated through miR-193a-3p silence. Fas apoptotic inhibitory molecule 2 (FAIM2) was predicted by bioinformatics analysis and further identified as a direct target gene of miR-193a-3p. Interestingly, the effect of miR-193a-3p inhibition under IH could be reversed by down-regulating FAIM2 expression. In conclusion, our study first revealed that miR-193a-3p inhibition could protect HUVECs against intermittent hypoxia-induced damage by negatively regulating FAIM2. These findings could advance our understanding of the underlying mechanisms for OSA-related cardiac injury. We exposed HUVECs to IH condition; the expression levels of miR-193a-3p were detected by RT-qPCR. Cell viability, and the expressions of apoptosis-associated proteins were examined via CCK-8, and western blotting, respectively. Target genes of miR-193a-3p were confirmed by dual-luciferase reporter assay.Keywords
This publication has 48 references indexed in Scilit:
- The Relationship between Obstructive Sleep Apnea and Alzheimer’s DiseaseJournal of Alzheimer’s Disease, 2018
- Which place of pharmacological approaches beyond continuous positive airway pressure to treat vascular disease related to obstructive sleep apnea?Pharmacology & Therapeutics, 2017
- Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammationEuropean Respiratory Journal, 2017
- Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta‐analysisRespirology, 2015
- Prevalence of sleep-disordered breathing in the general population: the HypnoLaus studyThe Lancet Respiratory Medicine, 2015
- Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literatureSleep Medicine Reviews, 2015
- Chronic Sleep Fragmentation Induces Endothelial Dysfunction and Structural Vascular Changes in MiceSLEEP, 2014
- Increased Prevalence of Sleep-Disordered Breathing in AdultsAmerican Journal of Epidemiology, 2013
- Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of HypertensionJAMA, 2012
- Endothelial Function and Arterial Stiffness in Minimally Symptomatic Obstructive Sleep ApneaAmerican Journal of Respiratory and Critical Care Medicine, 2008